373 related articles for article (PubMed ID: 11680517)
21. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
Dohare P; Garg P; Jain V; Nath C; Ray M
Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
[TBL] [Abstract][Full Text] [Related]
22. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
Sydserff SG; Borelli AR; Green AR; Cross AJ
Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
[TBL] [Abstract][Full Text] [Related]
23. Tacrolimus (FK506) limits accumulation of granulocytes and platelets and protects against brain damage after transient focal cerebral ischemia in rat.
Noto T; Furuichi Y; Ishiye M; Matsuoka N; Aramori I; Mutoh S; Yanagihara T
Biol Pharm Bull; 2007 Feb; 30(2):313-7. PubMed ID: 17268072
[TBL] [Abstract][Full Text] [Related]
24. Treatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506.
Ishii T; Asai T; Oyama D; Agato Y; Yasuda N; Fukuta T; Shimizu K; Minamino T; Oku N
FASEB J; 2013 Apr; 27(4):1362-70. PubMed ID: 23241312
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic time window for treatment of focal cerebral ischemia reperfusion injury with XQ-1h in rats.
Sun J; Li Y; Fang W; Mao L
Eur J Pharmacol; 2011 Sep; 666(1-3):105-10. PubMed ID: 21645512
[TBL] [Abstract][Full Text] [Related]
26. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.
Nakai A; Kuroda S; Kristián T; Siesjö BK
Neurobiol Dis; 1997; 4(3-4):288-300. PubMed ID: 9361306
[TBL] [Abstract][Full Text] [Related]
27. FK506 reduces infarct volume due to permanent focal cerebral ischemia by maintaining BAD turnover and inhibiting cytochrome c release.
Shichinohe H; Kuroda S; Abumiya T; Ikeda J; Kobayashi T; Yoshimoto T; Iwasaki Y
Brain Res; 2004 Mar; 1001(1-2):51-9. PubMed ID: 14972653
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.
Gupta S; Kaul CL; Sharma SS
Neurol Res; 2004 Jan; 26(1):103-7. PubMed ID: 14977067
[TBL] [Abstract][Full Text] [Related]
29. Synergistic efficacy of magnesium sulfate and FK506 on cerebral ischemia-induced infarct volume in gerbil.
Chung SY; Lin JY; Lin MC; Liu HM; Wang MF; Cheng FC
Med Sci Monit; 2004 Apr; 10(4):BR105-8. PubMed ID: 15039639
[TBL] [Abstract][Full Text] [Related]
30. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia.
Bao WL; Williams AJ; Faden AI; Tortella FC
Brain Res; 2001 Dec; 922(2):173-9. PubMed ID: 11743947
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective activity of tamoxifen in permanent focal ischemia.
Kimelberg HK; Jin Y; Charniga C; Feustel PJ
J Neurosurg; 2003 Jul; 99(1):138-42. PubMed ID: 12854756
[TBL] [Abstract][Full Text] [Related]
32. Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats.
Park SY; Lee JH; Kim CD; Rhim BY; Hong KW; Lee WS
Brain Res; 2007 Jul; 1157():112-20. PubMed ID: 17521620
[TBL] [Abstract][Full Text] [Related]
33. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.
Zhao Y; Patzer A; Gohlke P; Herdegen T; Culman J
Eur J Neurosci; 2005 Jul; 22(1):278-82. PubMed ID: 16029218
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor.
Foster KA; Regan HK; Danziger AP; Detwiler T; Kwon N; Rickert K; Lynch JJ; Regan CP
Neurosci Res; 2009 Jan; 63(1):10-6. PubMed ID: 18951929
[TBL] [Abstract][Full Text] [Related]
35. Pentoxifylline attenuates TNF-α protein levels and brain edema following temporary focal cerebral ischemia in rats.
Vakili A; Mojarrad S; Akhavan MM; Rashidy-Pour A
Brain Res; 2011 Mar; 1377():119-25. PubMed ID: 21219888
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: role of glutamate uptake and FK506 binding protein 12 kDa.
Labrande C; Velly L; Canolle B; Guillet B; Masmejean F; Nieoullon A; Pisano P
Neuroscience; 2006; 137(1):231-9. PubMed ID: 16289353
[TBL] [Abstract][Full Text] [Related]
37. Effect of long-term administration of JTP-2942, a novel thyrotropin-releasing hormone analogue, on neurological outcome, local cerebral blood flow and glucose utilization in a rat focal cerebral ischemia.
Katsumata T; Katayama Y; Ootori T; Muramatsu H; Nishiyama Y; Nakamura H; Seta T; Terashi A
Brain Res; 2001 May; 901(1-2):62-70. PubMed ID: 11368951
[TBL] [Abstract][Full Text] [Related]
38. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G
Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255
[TBL] [Abstract][Full Text] [Related]
39. FK506 attenuates early ischemic neuronal death in a monkey model of stroke.
Takamatsu H; Tsukada H; Noda A; Kakiuchi T; Nishiyama S; Nishimura S; Umemura K
J Nucl Med; 2001 Dec; 42(12):1833-40. PubMed ID: 11752082
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats.
Tan F; Li H; Ma M; Yu Y
Brain Res; 2014 Apr; 1560():83-90. PubMed ID: 24602692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
